HIPRA Biotech Services is a CDMO supporting pharma and biotech companies through the full lifecycle of biologics and vaccines, drawing on more than 50 years of expertise and its own COVID vaccine to offer end-to-end development and GMP manufacturing across viral, mammalian and microbial platforms for clinical and commercial drug substance and product. With more than 400 R&D scientists and 1,000 engineers, operators and analysts, the company ensures quality, speed and flexibility across its projects.

No comments available.
Leave your rating & comment